National guidelines for decolonization of methicillin-resistant staphylococcus aureus carriers: The implications of recent experience in the Netherlands

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 10, 2011, Pages 2195-2198

  Tacconelli, Evelina ^a   Johnson, Alan P ^b  

^a CATHOLIC UNIVERSITY   (Italy)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Carriage; Infection control; MRSA; Nosocomial infections

Indexed keywords

ANTIBIOTIC AGENT; CHLORHEXIDINE; COTRIMOXAZOLE; PSEUDOMONIC ACID; RIFAMPICIN;

ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL TRANSMISSION; BACTERIUM CARRIER; BACTERIUM DECOLONIZATION; CLINICAL EFFECTIVENESS; COST EFFECTIVENESS ANALYSIS; DAILY LIFE ACTIVITY; DISEASE SURVEILLANCE; DRUG EFFICACY; ERADICATION THERAPY; HOSPITAL PATIENT; HOUSEHOLD; HUMAN; INFECTION CONTROL; INFECTION RISK; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NETHERLANDS; NONHUMAN; PRACTICE GUIDELINE; TREATMENT FAILURE;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS, LOCAL; CARRIER STATE; FEMALE; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCAL INFECTIONS;

EID: 80052899929     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr309     Document Type: Article

References (21)

1. Tacconelli E. Methicillin-resistant Staphylococcus aureus: source control and surveillance organization. Clin Microbiol Infect 2009; 15 Suppl 7: 31-8.
2. Boyce T, Murray E, Holmes A. What are the drivers of the UK media coverage of meticillin-resistant Staphylococcus aureus, the inter-relationships and relative influences? J Hosp Infect 2009; 73: 400-7.
3. Kalenic S, Cookson B, Gallagher R et al. Comparison of recommendations in national/regional Guidelines for prevention and control of MRSA in thirteen European countries. Int J Infect Control 2010; v6: i2 (www.ijic.info/article/download/5138/4212).
4. Cookson B, Bonten MJ, Mackenzie FM et al. Meticillin-resistant Staphylococcus aureus (MRSA): screening and decolonisation. Int J Antimicrob Agents 2011; 37: 195-201.
5. Coia JE, Duckworth GJ, Edwards DI et al. for the Joint Working Party of the British Society of Antimicrobial Chemotherapy, the Hospital Infection Society, and the Infection Control Nurses Association. Guidelines for the control and prevention of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities. J Hosp Infect 2006; 63 Suppl 1: S1-44.
6. Salgado CD, Farr BM. What proportion of hospital patients colonized with methicillin-resistant Staphylococcus aureus are identified by clinical microbiological cultures? Infect Control Hosp Epidemiol 2006; 27: 116-21.
7. Safdar N, Bradley EA. The risk of infection after nasal colonization with Staphylococcus aureus. Am J Med 2008; 121: 310-5.
8. McGinigle KL, Gourlay ML, Buchanan IB. The use of active surveillance cultures in adult intensive care units to reduce methicillin-resistant Staphylococcus aureus-related morbidity, mortality, and costs: a systematic review. Clin Infect Dis 2008; 46: 1717-25.
9. Ellis MW, Griffith ME, Jorgensen JH et al. Presence and molecular epidemiology of virulence factors in methicillin-resistant Staphylococcus aureus strains colonizing and infecting soldiers. J Clin Microbiol 2009; 47: 940-5.
10. Bootsma MC, Diekmann O, Bonten MJ. Controlling methicillinresistant Staphylococcus aureus: quantifying the effects of interventions and rapid diagnostic testing. Proc Natl Acad Sci USA 2006; 103: 5620-5.
11. Gagliotti C, Balode A, Baquero F et al. Escherichia coli and Staphylococcus aureus: bad news and good news from the European Antimicrobial Resistance Surveillance Network (EARS-Net, formerly EARSS), 2002 to 2009. Euro Surveill 2011; 16: pii=19819.
12. Edgeworth JD. Has decolonization played a central role in the decline in UK methicillin-resistant Staphylococcus aureus transmission? A focus on evidence from intensive care. J Antimicrob Chemother 2011; 66 Suppl 2: ii41-7.
13. Millar M. Should we screen low risk patients for meticillin resistant Staphylococcus aureus? BMJ 2009; 339: b4035.
14. Ammerlaan HSM, Kluytmans JAJW, Berkhout H et al. Eradication of carriage with methicillin-resistant Staphylococcus aureus: effectiveness of a national guideline. J Antimicrob Chemother 2011; 66: 2409-17.
15. Ammerlaan HSM, Kluytmans JAJW, Berkhout H et al. Eradication of carriage with methicillin-resistant Staphylococcus aureus: determinants of treatment failure. J Antimicrob Chemother 2011; 66: 2418-24.
16. Nelson RE, Samore MH, Smith KJ et al. Cost-effectiveness of adding decolonization to a surveillance strategy of screening and isolation for methicillin-resistant Staphylococcus aureus carriers. Clin Microbiol Infect 2010; 16: 1740-6.
17. Wendt C, Schinke S, Wurttemberger M et al. Value of whole-body washing with chlorhexidine for the eradication of methicillin-resistant Staphylococcus aureus: a randomized, placebo-controlled, double-blind clinical trial. Infect Control Hosp Epidemiol 2007; 28: 1036-43.
18. Larsen AR, Stegger M, Böcher S et al. Emergence and characterization of community-associated methicillin-resistant Staphylococcus aureus infections in Denmark, 1999 to 2006. J Clin Microbiol 2009; 47: 73-8.
19. Ammerlaan HS, Kluytmans JA, Wertheim HF et al. Eradication of methicillin-resistant Staphylococcus aureus carriage: a systematic review. Clin Infect Dis 2009; 48: 922-30.
20. Lee AS, Macedo-Vinas M, François P et al. Impact of combined low-level mupirocin and genotypic chlorhexidine resistance on persistent methicillin-resistant Staphylococcus aureus carriage after decolonization therapy: a case-control study. Clin Infect Dis 2011; 52: 1422-30.
21. Shorr AF. Epidemiology and economic impact of meticillin-resistant Staphylococcus aureus: review and analysis of the literature. Pharmacoeconomics 2007; 25: 751-68.